sizzl posit sector read
post earn revenu beat greater normal clearli posit
better higher margin growth profil year work
life scienc sector robust da post growth growth
typic analyt instrument peer agil buy thermo fisher buy
posit beat see higher level valuat go forward
rais fair valu
earn model updat post organ growth rel
estim da analyt report diagnost growth
ep versu consensu
updat model reflect complet euroimmun acquisit management
indic euroimmun add ep importantli
acquisit increas dx revenu base
previou accret analysi estim euroimmun drive
increment ep
revenu come china america believ
realiz cross-sel synergi china leverag regulatori expertis
introduc euroimmun product market
 autoimmun opportun autoimmun diseas occur bodi
abnorm immun respons normal bodi part affect
american euroimmun deriv revenu america
howev believ regulatori expertis could see america busi
grow long-term
meaning margin expans opportun management indic
dx opm nowher near matur euroimmun
neutral margin near-term view high recur revenu
profil opportun meaning expand margin toward
legaci dx margin compani high recur revenu run
opm
compel goal indic organ growth goal upper
singl digit oper margin rel growth today
margin
fair valu fv reach appli multipl
consolid ep multipl midpoint last two
year forward pe fv also reach appli
da revenu estim per share
dx revenu per share less net debt per share
million except per share data
yoy growth countri
geograph sale
annual revenu break-out margin
revenu
total sale
revenu
